Akebia Therapeutics Inc. buy Lokrim
Start price
18.03.24
/
20%
€1.73
Target price
18.03.25
-
Performance (%)
-23.70%
End price
17.08.24
€1.32
Summary
This prediction ended on 17.08.24 with a price of €1.32. The prediction for Akebia Therapeutics Inc. disappointed with a performance of -23.70%. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 5.327% | 5.327% | -20.505% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to Lokrim what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?
Pros
Medium risks for its business
Cons
Comments by Lokrim for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Buy Akebia Therapeutics Inc.